Your browser doesn't support javascript.
loading
Can-Pain-a digital intervention to optimise cancer pain control in the community: development and feasibility testing.
Adam, Rosalind; Bond, Christine M; Burton, Christopher D; de Bruin, Marijn; Murchie, Peter.
Afiliação
  • Adam R; Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Room 1:020, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. rosalindadam@abdn.ac.uk.
  • Bond CM; Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK.
  • Burton CD; Academic Unit of Primary Medical Care, University of Sheffield, Sheffield, England, UK.
  • de Bruin M; Health Psychology, Radboud University Medical Centre, Radboud Institute of Health Sciences, IQ Healthcare, Nijmegen, Netherlands.
  • Murchie P; Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK.
Support Care Cancer ; 29(2): 759-769, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32468132
ABSTRACT

PURPOSE:

To develop a novel digital intervention to optimise cancer pain control in the community. This paper describes intervention development, content/rationale and initial feasibility testing.

METHODS:

Determinants of suboptimal cancer pain management were characterised through two systematic reviews; patient, caregiver and healthcare professional (HCP) interviews (n = 39); and two HCP focus groups (n = 12). Intervention mapping was used to translate results into theory-based content, creating the app "Can-Pain". Patients with/without a linked caregiver, their general practitioners and community palliative care nurses were recruited to feasibility test Can-Pain over 4 weeks.

RESULTS:

Patients on strong opioids described challenges balancing pain levels with opioid intake, side effects and activities and communicating about pain management problems with HCPs. Can-Pain addresses these challenges through educational resources, contemporaneous short-acting opioid tracking and weekly patient-reported outcome monitoring. Novel aspects of Can-Pain include the use of contemporaneous breakthrough analgesic reports as a surrogate measure of pain control and measuring the level at which pain becomes bothersome to the individual. Patients were unwell due to advanced cancer, making recruitment to feasibility testing difficult. Two patients and one caregiver used Can-Pain for 4 weeks, sharing weekly reports with four HCPs. Can-Pain highlighted unrecognised problems, promoted shared understanding about symptoms between patients and HCPs and supported shared decision-making.

CONCLUSIONS:

Preliminary testing suggests that Can-Pain is feasible and could promote patient-centred pain management. We will conduct further small-scale evaluations to inform a future randomised, stepped-wedge trial. TRIAL REGISTRATION Qualitative research ClinicalTrials.gov , reference NCT02341846 Feasibility study NIHR CPMS database ID 34172.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Manejo da Dor / Dor do Câncer / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Manejo da Dor / Dor do Câncer / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article